CME CEO Clashes with CFTC and Kalshi Over Prediction Market Regulation

icon MarsBit
Share
AI summary iconSummary
CME Group CEO Terrence Duffy clashed with CFTC Chair Michael Selig and Kalshi’s Luana Lopes Lara during a recent advisory meeting on prediction market oversight. Duffy warned of manipulation risks in self-certified contracts, including those tied to events involving Trump and Maduro. Selig dismissed the claims as “fake news,” noting that the products were not listed in the U.S. The dispute underscores regulatory tensions surrounding CFT compliance and jurisdiction. As liquidity and crypto markets evolve, friction between federal and state regulators is intensifying.

Huoxing Finance reports that on August 21, Terrence Duffy, CEO of CME Group, engaged in a heated exchange with CFTC Chairman Michael Selig and Kalshi COO Luana Lopes Lara during a meeting of the CFTC’s Innovation and Technology Advisory Committee on the issue of regulatory oversight of prediction markets. Duffy expressed concerns that certain prediction market contracts pose manipulation risks, particularly those listed through self-certification. He highlighted specific contracts related to the content of Trump’s State of the Union address and the timing of Venezuela’s President Maduro’s departure from office as potentially susceptible to manipulation, arguing that such practices harm the entire industry. Selig immediately interrupted, stating that the products Duffy referenced are not listed in the U.S. and that the events in question occurred overseas, calling Duffy’s claims “fake news.” Duffy responded that he was merely raising market risks and indicated willingness to continue the discussion if needed. As the prediction market grows rapidly, disputes over regulatory jurisdiction between U.S. federal agencies and state governments are intensifying. Some state governments argue that prediction contracts tied to sporting events constitute gambling and may violate state gambling laws; however, Selig asserted that the CFTC holds “exclusive jurisdiction” over prediction markets and has already initiated litigation against multiple states over these regulatory conflicts. Selig stated that the CFTC plans to further revise its rules to strengthen listing requirements for event contracts and enhance consumer protection standards, noting that regulators have fully acknowledged market concerns regarding insufficient protection for retail consumers. Prediction markets have recently faced allegations of insider trading and market manipulation. The U.S. Congress has proposed legislation to ban the listing of sports and casino-related prediction contracts on registered platforms. Both Kalshi and Polymarket have introduced new measures to combat insider trading and market manipulation. In the latter part of the meeting, Kalshi COO Lopes Lara challenged Duffy, asking whether CME had ever experienced market manipulation. Duffy replied that CME’s regulatory staff outnumbered Kalshi’s entire company. Lopes Lara retorted that he should learn how to improve efficiency. The two then continued their debate on issues such as “trusted markets.” Currently, prediction markets stand at a regulatory crossroads, where jurisdictional conflicts between the CFTC and state regulators, as well as competition between traditional derivatives exchanges and emerging prediction market platforms, may significantly shape the future trajectory of this market.

Disclaimer: The information on this page may have been obtained from third parties and does not necessarily reflect the views or opinions of KuCoin. This content is provided for general informational purposes only, without any representation or warranty of any kind, nor shall it be construed as financial or investment advice. KuCoin shall not be liable for any errors or omissions, or for any outcomes resulting from the use of this information. Investments in digital assets can be risky. Please carefully evaluate the risks of a product and your risk tolerance based on your own financial circumstances. For more information, please refer to our Terms of Use and Risk Disclosure.